🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to provide continued treatment with eltromb...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-10-15
Trial ID
NCT01957176
Treatments Being Tested
This was a non-randomized, open-label, phase II study to assess the efficac...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-23
Trial ID
NCT02148133
Treatments Being Tested
Bone marrow failure disease(BMFD) is a kind of bone marrow due to congenita...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2022-10-22
Trial ID
NCT05466201
Treatments Being Tested
Study rationale is based on the data that in previous clinical studies of e...
Status
Completed
Location
Weill Cornell Medicine
Start Date
2013-02
Trial ID
NCT01880047
Treatments Being Tested
The purpose of this project is to describe the pathophysiology of thrombocy...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2009-06
Trial ID
NCT00909363
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of eltrombopag ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-11-04
Trial ID
NCT04328727
Treatments Being Tested
The purpose of this study was to evaluate the efficacy of eltrombopag for p...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2018-12-17
Trial ID
NCT03718533
Treatments Being Tested
This is a randomized, open-label, five-period, balanced crossover study con...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01-12
Trial ID
NCT01072162
Treatments Being Tested
Primary immune thrombocytopenia (ITP) is an acquired autoimmune hemorrhagic...
Status
Unknown
Location
Zhou Yiming
Start Date
2019-01-16
Trial ID
NCT03771378
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of eltrom...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-05-11
Trial ID
NCT02998645
Treatments Being Tested